Multimeric RNA Aptamers for Glucose-Responsive Insulin Formulations
SMARTCELLS, INC. · Department of Health and Human Services
Phase I2007$394,363
DESCRIPTION (provided by applicant): The landmark Diabetes Control and Complications Trial (DCCT) and the UK Prospective Diabetes Study (UKPDS), have clinically proven that tighter glycemic control, as measured by lower…